We are live on ! Find out more
ICCM icon

IceCure Medical
ICCM

17 hedge funds and large institutions have $319K invested in IceCure Medical in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

150% more capital invested

Capital invested by funds: $127K → $319K (+$191K)

42% more funds holding

Funds holding: 12 → 17 (+5)

0% more ownership

Funds ownership: 0.02% → 0.02% (+0%)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
17
Holders Change
+5
Holders Change %
+41.67%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
2
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
+$33.1K
2
XT
XTX Topco
Cayman Islands
+$15.8K
3
Renaissance Technologies
Renaissance Technologies
New York
+$14.6K
4
Jane Street
Jane Street
New York
+$14.1K
5
Morgan Stanley
Morgan Stanley
New York
+$10.7K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$19K
2
Barclays
Barclays
United Kingdom
-$9.78K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$8.6K
4
TSS
Two Sigma Securities
New York
-$6.44K
5
VF
Virtu Financial
New York
-$3.73K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$54.7K -$19K -717 -30%
HF
2
HRT Financial
New York
$40K +$33.1K +1,251 New
Bank of America
3
Bank of America
North Carolina
$29.3K – – –
UBS Group
4
UBS Group
Switzerland
$22.3K +$5.32K +201 +41%
VF
5
Virtu Financial
New York
$21K -$3.73K -141 -18%
AWM
6
AE Wealth Management
Kansas
$20.4K +$212 +8 +2%
XT
7
XTX Topco
Cayman Islands
$19.2K +$15.8K +598 New
Renaissance Technologies
8
Renaissance Technologies
New York
$18K +$14.6K +550 New
TSS
9
Two Sigma Securities
New York
$17.7K -$6.44K -243 -31%
Jane Street
10
Jane Street
New York
$17K +$14.1K +531 New
SIGI
11
Susquehanna International Group (Ireland)
Ireland
$16.3K – – –
FIA
12
Foundations Investment Advisors
Arizona
$14.2K +$8.82K +333 New
Morgan Stanley
13
Morgan Stanley
New York
$13K +$10.7K +405 New
Osaic Holdings
14
Osaic Holdings
Arizona
$7.76K +$6.41K +242 New
JP Morgan Chase
15
JP Morgan Chase
New York
$6.37K – – –
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$1K – – –
TRCT
17
Tower Research Capital (TRC)
New York
$315 – – –
Barclays
18
Barclays
United Kingdom
– -$9.78K -603 Closed
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
– -$8.6K -517 Closed

ICCM Hedge Fund Activity: Q4 2023 in Review

17 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q4 2023, worth a combined $319K — up 150% from $127K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ICCM positions and 2 closed out — a net gain of 5 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $33.1K. The largest seller was Citadel Advisors, cutting an estimated $19K.

  • 17 institutional investors held IceCure Medical (ICCM) as of Q4 2023, up from 12 in Q3 2023.
  • Funds reported $319K of IceCure Medical stock for Q4 2023, up 150% quarter-over-quarter.
  • 7 funds opened new IceCure Medical positions in Q4 2023 and 2 closed out, a net change of +5 holders.
  • The largest IceCure Medical buyer in Q4 2023 was HRT Financial, an estimated $33.1K added.
  • The largest IceCure Medical seller in Q4 2023 was Citadel Advisors, an estimated $19K sold.

Based on aggregated 13F filings for Q4 2023.